Literature DB >> 11839955

Presymptomatic diagnosis for children of sporadic neurofibromatosis 2 patients: a method based on tumor analysis.

Lan Kluwe1, Reinhard E Friedrich, Marcos Tatagiba, Victor F Mautner.   

Abstract

PURPOSE: To provide presymptomatic diagnosis for children of sporadic neurofibromatosis 2 patients in whom no NF2-mutations were found by screening their blood-DNA.
METHODS: Tumors of four patients were analyzed for NF2 allele losses and mutations.
RESULTS: Nonsense NF2 mutations and NF2 allele losses were found in all tumors. None of these alterations was found in any of eight children examined, suggesting that these children did not inherit the disease.
CONCLUSIONS: Finding two genetic alterations of a tumor suppressor gene in associated tumors is useful for presymptomatic diagnosis. Identification of the lost allele in tumors alone also enables exclusion of disease transmission in 50% of cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839955     DOI: 10.1097/00125817-200201000-00005

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  3 in total

1.  Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.

Authors:  D Gareth R Evans; R T Ramsden; A Shenton; C Gokhale; N L Bowers; S M Huson; G Pichert; A Wallace
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

2.  Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.

Authors:  L Kluwe; V Mautner; B Heinrich; R Dezube; L B Jacoby; R E Friedrich; M MacCollin
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

Review 3.  Neurofibromatosis type 2 (NF2): a clinical and molecular review.

Authors:  D Gareth R Evans
Journal:  Orphanet J Rare Dis       Date:  2009-06-19       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.